Abstract
The impact of proton pump inhibitor (PPI) administration on the antiplatelet effect of clopidogrel remains controversial. Studies suggest that mechanistic interactions between these medications may lead to higher rates of adverse cardiac events after myocardial infarction or coronary intervention. The objective of this study is to evaluate the effects of concurrent PPI and clopidogrel administration on outcomes after peripheral endovascular interventions.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
